• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有增强组蛋白脱乙酰酶抑制活性的新型硫化丙戊酸衍生物。

New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity.

作者信息

Perrino Elena, Cappelletti Graziella, Tazzari Valerio, Giavini Erminio, Del Soldato Piero, Sparatore Anna

机构信息

Sulfidris s.r.l., Viale Gran Sasso 17, 20131 Milan, Italy.

出版信息

Bioorg Med Chem Lett. 2008 Mar 15;18(6):1893-7. doi: 10.1016/j.bmcl.2008.02.007. Epub 2008 Feb 8.

DOI:10.1016/j.bmcl.2008.02.007
PMID:18294844
Abstract

One dithiolthione and two new methanethiosulfonate derivatives of valproic acid (VPA) were synthesized and tested in vitro as histone deacetylase (HDAC) inhibitors. The new molecules, as well as their sulfurated moieties, exhibited a much stronger inhibition of HDAC enzymatic and antiproliferative activities and histone hyperacetylation than VPA. ACS 2 is the most interesting compound among the new VPA derivatives and its sulfurated moiety, 5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione, also known to be a metabolite of anethole trithione, seems to contribute significantly to its activity. This is the first time that HDAC inhibitory activity is described for dithiolethiones and thiosulfonates.

摘要

合成了一种二硫代硫酮和两种丙戊酸(VPA)的新型甲硫基磺酸盐衍生物,并在体外作为组蛋白脱乙酰酶(HDAC)抑制剂进行了测试。这些新分子及其硫化部分对HDAC酶活性、抗增殖活性和组蛋白高乙酰化的抑制作用比VPA强得多。ACS 2是新型VPA衍生物中最有趣的化合物,其硫化部分5-(4-羟基苯基)-3H-1,2-二硫代-3-硫酮(也已知是茴芹内酯三硫酮的一种代谢物)似乎对其活性有显著贡献。这是首次报道二硫代硫酮和硫代磺酸盐具有HDAC抑制活性。

相似文献

1
New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity.具有增强组蛋白脱乙酰酶抑制活性的新型硫化丙戊酸衍生物。
Bioorg Med Chem Lett. 2008 Mar 15;18(6):1893-7. doi: 10.1016/j.bmcl.2008.02.007. Epub 2008 Feb 8.
2
Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.由组蛋白脱乙酰酶抑制介导的致畸作用:来自20种丙戊酸衍生物的定量构效关系的证据。
Chem Res Toxicol. 2006 Feb;19(2):272-8. doi: 10.1021/tx0502241.
3
Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.丙戊酸增加人巨细胞病毒在视网膜色素上皮细胞中的复制依赖于组蛋白脱乙酰酶抑制作用。
Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3451-7. doi: 10.1167/iovs.05-0369.
4
S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite s-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mouse model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further valproic acid hydroxamates and amides.NMRI无脑畸形小鼠模型中的S-2-戊基-4-戊炔酸异羟肟酸及其代谢产物S-2-戊基-4-戊炔酸:其他丙戊酸异羟肟酸酯和酰胺的药代动力学特征、致畸作用及组蛋白去乙酰化酶抑制能力
Drug Metab Dispos. 2006 Apr;34(4):612-20. doi: 10.1124/dmd.105.008078. Epub 2006 Jan 13.
5
Histone deacetylase inhibitor valproic acid inhibits proliferation and induces apoptosis in KM3 cells via downregulating VEGF receptor.组蛋白去乙酰化酶抑制剂丙戊酸通过下调血管内皮生长因子受体抑制KM3细胞增殖并诱导其凋亡。
Neuro Endocrinol Lett. 2007 Dec;28(6):775-80.
6
Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition.
Bioorg Med Chem Lett. 2007 Aug 15;17(16):4491-4. doi: 10.1016/j.bmcl.2007.06.006. Epub 2007 Jun 6.
7
Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.组蛋白去乙酰化酶抑制剂丙戊酸对致死性失血性休克的肝保护作用及致死率挽救
J Trauma. 2008 Sep;65(3):554-65. doi: 10.1097/TA.0b013e31818233ef.
8
Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity.组蛋白去乙酰化酶活性对特定胚胎组织的抑制作用作为致畸性的一种新机制。
Birth Defects Res B Dev Reprod Toxicol. 2005 Oct;74(5):392-8. doi: 10.1002/bdrb.20053.
9
Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid.组蛋白去乙酰化酶抑制剂丙戊酸对结肠癌细胞和胰腺癌细胞黏附及生长的调节作用
Int J Mol Med. 2008 Sep;22(3):293-9.
10
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.组蛋白去乙酰化酶抑制剂丙戊酸诱导的体内抗骨髓瘤活性及基因表达谱调控
Br J Haematol. 2008 Nov;143(4):520-31. doi: 10.1111/j.1365-2141.2008.07387.x.

引用本文的文献

1
HS Donors with Cytoprotective Effects in Models of MI/R Injury and Chemotherapy-Induced Cardiotoxicity.在心肌梗死/再灌注损伤和化疗诱导的心脏毒性模型中具有细胞保护作用的造血干细胞供体。
Antioxidants (Basel). 2023 Mar 5;12(3):650. doi: 10.3390/antiox12030650.
2
HS Donors and Their Use in Medicinal Chemistry.HS 供体及其在药物化学中的应用。
Biomolecules. 2021 Dec 18;11(12):1899. doi: 10.3390/biom11121899.
3
Trends in HS-Donors Chemistry and Their Effects in Cardiovascular Diseases.造血干细胞供体化学的趋势及其在心血管疾病中的作用
Antioxidants (Basel). 2021 Mar 11;10(3):429. doi: 10.3390/antiox10030429.
4
Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors.硫化氢在药物治疗中的应用,超越硫化氢供体
Biomolecules. 2020 Feb 18;10(2):323. doi: 10.3390/biom10020323.
5
A review of hydrogen sulfide (HS) donors: Chemistry and potential therapeutic applications.硫化氢(HS)供体综述:化学性质与潜在治疗应用。
Biochem Pharmacol. 2018 Mar;149:110-123. doi: 10.1016/j.bcp.2017.11.014. Epub 2017 Nov 23.
6
Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain.甲硫基磺酸盐衍生物作为信号转导和转录激活因子3(STAT3)-Src同源2(SH2)结构域的配体
J Enzyme Inhib Med Chem. 2017 Dec;32(1):337-344. doi: 10.1080/14756366.2016.1252757.
7
Development of hydrogen sulfide-based therapeutics for cardiovascular disease.基于硫化氢的心血管疾病治疗药物的研发。
J Cardiovasc Transl Res. 2010 Oct;3(5):487-98. doi: 10.1007/s12265-010-9201-y. Epub 2010 Jul 14.
8
Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.二硫代烯丙氨酸修饰的丙戊酸和双氯芬酸增加非小细胞肺癌细胞中 E-钙黏蛋白的表达并降低其增殖。
Lung Cancer. 2010 May;68(2):154-60. doi: 10.1016/j.lungcan.2009.06.012. Epub 2009 Jul 23.